^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    FirstSight™ CRC Test

    Company:
    CellMax Life
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    FirstSight™ CRC Test detects and analyzes circulating tumor cells (CTCs) and is intended to predict the likelihood of having precancerous adenomatous polyps or colorectal cancer (CRC) in patients eligible for CRC screening. The FirstSight assay evaluates 3 biomarkers: circulating gastrointestinal epithelial cells, validated somatic oncogene and tumor suppressor mutations, and methylation with Septin9 of cell-free tumor DNA (cfDNA).
    Cancer:
    Colorectal Cancer
    Method:
    Liquid biopsy